DDReg is thrilled to announce a significant milestone that is the establishment of its new entity in Cologne (Köln), Germany. This strategic development marks a pivotal moment for DDReg in expanding & enhancing its global presence and reflects DDReg’s commitment to better serve its customers in their requirements for/in the European market.
DDReg is confident that this establishment will facilitate unparalleled services and tailored solutions to support compliant and rapid market access in the European Union. Reach out to us at info@ddregpharma.com for more information on procedures in obtaining EU marketing authorization (MA), MA holder services, local QPPV support and more.
Visit us at:
DDReg Pharma GmbH
Rudolph Platz 3, 50678
Köln, Germany
News
DDReg Opens German Entity in Cologne (Köln)

Published March 14, 2024By DDReg Regulatory Team
Share
Related Blogs

·2 min read
NewsDDReg Honored at ET Health Conclave 2025 for Excellence in Life Sciences Services
·2 min read
NewsDDReg in the News
·3 min read
NewsQuantiphi, DDReg Partner to Transform Regulatory Reporting in Life Sciences Through AI
·3 min read
NewsManaging Director of DDReg chosen as finalist for CPhI Pharma Awards 2024
·1 min read
NewsDDReg Opens Entity in Singapore
·4 min read
NewsDDReg Managing Director wins ET RE Pharma “Woman Icon of the Year” Award 2024
·2 min read
NewsDDReg Participates in India Pharma Awards 2023 for Excellence in Ancillary Pharma Services
·2 min read
NewsDDReg attends the OTC Health and Wellness Conference 2023
·1 min read
NewsDDReg nominated for India 5000 Best MSME Awards 2023
·1 min read
NewsDDReg Shortlisted for 'Regulatory' by CPHI Pharma Awards 2023
·1 min read
NewsDDReg receives the ISO 27001:2013 certification for Information Security Management System
·2 min read
NewsDDReg attends National Conference on Pharmacovigilance and Clinical Research 2022- Chandigarh College of Pharmacy